Detalhe da pesquisa
1.
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
Nat Immunol
; 20(3): 257-264, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778250
2.
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study.
Hepatology
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768260
3.
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes.
J Hepatol
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548067
4.
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Ann Intern Med
; 176(12): 1648-1655, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38079642
5.
Comparison Between Radial and Femoral Artery Access for Transarterial Chemoembolisation in Patients With Hepatocellular Carcinoma.
Can Assoc Radiol J
; 75(1): 178-186, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37563785
6.
Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022.
Emerg Infect Dis
; 29(5): 1051-1054, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081594
7.
Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.
J Hepatol
; 78(3): 501-512, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423805
8.
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort.
J Viral Hepat
; 30(3): 232-241, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529681
9.
Securing wider EU commitment to the elimination of hepatitis C virus.
Liver Int
; 43(2): 276-291, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196744
10.
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
Pharmacoepidemiol Drug Saf
; 32(4): 486-495, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444965
11.
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Qual Life Res
; 32(12): 3427-3438, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587323
12.
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Ann Hepatol
; 28(6): 101141, 2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468096
13.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut
; 71(3): 593-604, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741640
14.
Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease.
Gut
; 71(2): 402-414, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479052
15.
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.
Kidney Int
; 102(6): 1228-1237, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36411019
16.
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus.
J Hepatol
; 76(2): 265-274, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606913
17.
Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort).
Liver Int
; 42(1): 249-252, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34825765
18.
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Liver Int
; 42(1): 38-49, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520614
19.
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Liver Int
; 42(6): 1386-1400, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35025128
20.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC Infect Dis
; 22(1): 94, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086481